Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation



Rating:

Share or cite this content

Citations should be made in the following way:
S. Hamada (Kyoto, Japan), K. Murase (Kyoto, Japan), Y. Tabara (Kyoto, Japan), T. Minami (Kyoto, Japan), N. Takahashi (Kyoto, Japan), Y. Nakatsuka (Kyoto, Japan), H. Takeyama (Kyoto, Japan), T. Hirai (Kyoto, Japan), F. Matsuda (Kyoto, Japan), T. Handa (Kyoto, Japan), K. Chin (Kyoto, Japan). Impact of alpha-1 antitrypsin level on longitudinal lung function change: The Nagahama Study. 2025

Member's Comments

No comment yet.

Related content which might interest you: Heterogeneity in lung function of PiZZ alpha 1 antitrypsin deficiency: Impact of occupation in predicting disease severity Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study Source: Eur Respir J 2005; 26: Suppl. 49, 361s Year: 2005 Lung function in relation to emphysema development in alpha-1 antitrypsin deficiency Source: International Congress 2019 – Insights into physiological diagnostic services Year: 2019 Change in lung function and CT lung density in alpha1 antitrypsin deficiency patients under augmentation therapy Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Pilot study for detection of alpha-1 antitrypsin deficiency in a targeted Argentinean population Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Characteristics of zz alpha-1 antitrypsin deficiency patients on the Irish national registry Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 COPD and alpha-1 antitrypsin deficiency emphysema: characteristics and survival after Lung Transplantation Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Late Breaking Abstract - Impact of COVID-19 on patients with severe alpha1 antitrypsin deficiency: the IMCA1 study of the EARCO ERS Clinical Research Collaboration, preliminary findings. Source: Virtual Congress 2021 – Back to infection basics Year: 2021 Therapeutic efficacy of alpha-1 antitrypsin (AAT) augmentation therapy on the loss of lung tissue: an integrated analysis Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD Year: 2008 Characterization of lung function trajectories in the Raine Study Source: Virtual Congress 2020 – Management of chronic lung conditions Year: 2020 The Irish national alpha-1 antitrypsin deficiency targeted detection programme Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 Prevalence of alpha-1 antitrypsin deficiency (AATD) in Greater Glasgow and Clyde (GG&C) and current practises Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Implementation of screening program for alpha-1 antitrypsin deficiency in Spain Source: Annual Congress 2004 - Emphysema and oxygen therapy Year: 2004 Decline in health status in alpha1 antitrypsin deficiency Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Late Breaking Abstract - Genetic diagnosis of alpha-1 antitrypsin deficiency using saliva samples Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020 Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Regional deposition of 99mTc-labelled alpha-1 antitrypsin (AAT) in patients with alpha-1 antitrypsin deficiency and cystic fibrosis (CF) compared with healthy volunteers Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects Year: 2007 LSC - 2020 - Investigating the effect of Z alpha-1 antitrypsin expression on mitochondrial injury Source: Virtual Congress 2020 – Metabolic alterations and ageing in lung disease Year: 2020 Baseline characteristics of patients enrolled in the EARCO prospective registry of alpha-1 antitrypsin deficiency: preliminary results. Source: Virtual Congress 2021 – Treatments for airway diseases Year: 2021